{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:32Z","timestamp":1790717192313,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,24]]},"DOI":"10.7759\/cureus.67654","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T09:49:16Z","timestamp":1724492956000},"source":"Crossref","is-referenced-by-count":8,"title":["Gastroesophageal Reflux Disease: New Insights and Treatment Approaches"],"prefix":"10.7759","author":[{"given":"FNU","family":"Tanvir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkamal Singh","family":"Nijjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti Kaur","family":"Aulakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumerjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwarmandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinandan","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay Pal Singh","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivansh","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman","family":"Antaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil N","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006, 101:1900-20; quiz 1943. 10.1111\/j.1572-0241.2006.00630.x","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag HB","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014, 63:871-80. 10.1136\/gutjnl-2012-304269","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis","volume":"67","author":"Eusebi LH","year":"2018","unstructured":"Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018, 67:430-40. 10.1136\/gutjnl-2016-313589","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03189.x","article-title":"Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity","volume":"25","author":"Dubois RW","year":"2007","unstructured":"Dubois RW, Aguilar D, Fass R, et al.. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther. 2007, 25:487-500. 10.1111\/j.1365-2036.2006.03189.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018","volume":"156","author":"Peery AF","year":"2019","unstructured":"Peery AF, Crockett SD, Murphy CC, et al.. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019, 156:254-72.e11. 10.1053\/j.gastro.2018.08.063","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus","volume":"67","author":"Gyawali CP","year":"2018","unstructured":"Gyawali CP, Kahrilas PJ, Savarino E, et al.. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018, 67:1351-62. 10.1136\/gutjnl-2017-314722","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2011.01816.x","article-title":"Ambulatory high-resolution manometry, lower esophageal sphincter lift and transient lower esophageal sphincter relaxation","volume":"24","author":"Mittal RK","year":"2012","unstructured":"Mittal RK, Karstens A, Leslie E, Babaei A, Bhargava V. Ambulatory high-resolution manometry, lower esophageal sphincter lift and transient lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2012, 24:40-6. 10.1111\/j.1365-2982.2011.01816.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.053","article-title":"Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux","volume":"130","author":"Bredenoord AJ","year":"2006","unstructured":"Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology. 2006, 130:334-40. 10.1053\/j.gastro.2005.10.053","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.051","article-title":"Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease","volume":"139","author":"Boeckxstaens GE","year":"2010","unstructured":"Boeckxstaens GE, Beaumont H, Mertens V, et al.. Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology. 2010, 139:409-17. 10.1053\/j.gastro.2010.04.051","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.384","article-title":"Weak peristalsis in esophageal pressure topography: classification and association with dysphagia","volume":"106","author":"Roman S","year":"2011","unstructured":"Roman S, Lin Z, Kwiatek MA, Pandolfino JE, Kahrilas PJ. Weak peristalsis in esophageal pressure topography: classification and association with dysphagia. Am J Gastroenterol. 2011, 106:349-56. 10.1038\/ajg.2010.384","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01138.x","article-title":"High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD","volume":"102","author":"Pandolfino JE","year":"2007","unstructured":"Pandolfino JE, Kim H, Ghosh SK, Clarke JO, Zhang Q, Kahrilas PJ. High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD. Am J Gastroenterol. 2007, 102:1056-63. 10.1111\/j.1572-0241.2007.01138.x","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.233049","article-title":"Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique","volume":"60","author":"Farre R","year":"2011","unstructured":"Farre R, Blondeau K, Clement D, et al.. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011, 60:885-92. 10.1136\/gut.2010.233049","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-011-0480-0","article-title":"Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients","volume":"47","author":"Savarino E","year":"2012","unstructured":"Savarino E, Zentilin P, Tutuian R, Pohl D, Gemignani L, Malesci A, Savarino V. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012, 47:159-68. 10.1007\/s00535-011-0480-0","journal-title":"J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz PO","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013, 108:308-29. 10.1038\/ajg.2012.444","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.200063","article-title":"Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study","volume":"59","author":"Dent J","year":"2010","unstructured":"Dent J, Vakil N, Jones R, et al.. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010, 59:714-21. 10.1136\/gut.2009.200063","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.02.001","article-title":"Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now?","volume":"16","author":"Vaezi MF","year":"2018","unstructured":"Vaezi MF, Katzka D, Zerbib F. Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now?. Clin Gastroenterol Hepatol. 2018, 16:1018-29.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2012.01384.x","article-title":"Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group","volume":"26","author":"Richter JE","year":"2013","unstructured":"Richter JE, Pandolfino JE, Vela MF, et al.. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group. Dis Esophagus. 2013, 26:755-65. 10.1111\/j.1442-2050.2012.01384.x","journal-title":"Dis Esophagus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301897","article-title":"Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors","volume":"61","author":"Sifrim D","year":"2012","unstructured":"Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012, 61:1340-54. 10.1136\/gutjnl-2011-301897","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13067","article-title":"Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group","volume":"29","author":"Roman S","year":"2017","unstructured":"Roman S, Gyawali CP, Savarino E, et al.. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017, 29:1-15. 10.1111\/nmo.13067","journal-title":"Neurogastroenterol Motil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.130","article-title":"Expert consensus document: advances in the physiological assessment and diagnosis of GERD","volume":"14","author":"Savarino E","year":"2018","unstructured":"Savarino E, Bredenoord AJ, Fox M, Pandolfino JE, Roman S, Gyawali CP. Expert consensus document: advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2018, 14:665-76. 10.1038\/nrgastro.2017.130","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s1542-3565(05)00021-2","article-title":"Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease","volume":"3","author":"Prakash C","year":"2005","unstructured":"Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2005, 3:329-34. 10.1016\/s1542-3565(05)00021-2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12299","article-title":"Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn","volume":"26","author":"Martinucci I","year":"2014","unstructured":"Martinucci I, de Bortoli N, Savarino E, et al.. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014, 26:546-55. 10.1111\/nmo.12299","journal-title":"Neurogastroenterol Motil"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2010.01.069","article-title":"Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP)","volume":"72","author":"Kwiatek MA","year":"2010","unstructured":"Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010, 72:272-8. 10.1016\/j.gie.2010.01.069","journal-title":"Gastrointest Endosc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-017-0667-9","article-title":"The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China","volume":"17","author":"Du X","year":"2017","unstructured":"Du X, Wang F, Hu Z, et al.. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China. BMC Gastroenterol. 2017, 17:10.1186\/s12876-017-0667-9","journal-title":"BMC Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell LR","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, et al.. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999, 45:172-80. 10.1136\/gut.45.2.172","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12511","article-title":"The natural history of gastro-esophageal reflux disease: a comprehensive review","volume":"30","author":"Savarino E","year":"2017","unstructured":"Savarino E, de Bortoli N, De Cassan C, et al.. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017, 30:1-9. 10.1111\/dote.12511","journal-title":"Dis Esophagus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00454.2009","article-title":"Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis","volume":"298","author":"Rieder F","year":"2010","unstructured":"Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010, 298:G571-81. 10.1152\/ajpgi.00454.2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato C","year":"2016","unstructured":"Scarpignato C, Gatta L, Zullo A, Blandizzi C. Effective and safe proton pump inhibitor therapy in acid-related diseases - a position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016, 14:179. 10.1186\/s12916-016-0718-z","journal-title":"BMC Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.322","article-title":"ACG Clinical Guideline: diagnosis and management of Barrett's esophagus","volume":"111","author":"Shaheen NJ","year":"2016","unstructured":"Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG Clinical Guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016, 111:30-51. 10.1038\/ajg.2015.322","journal-title":"Am J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.72","article-title":"Age at onset of GERD symptoms predicts risk of Barrett's esophagus","volume":"108","author":"Thrift AP","year":"2013","unstructured":"Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013, 108:915-22. 10.1038\/ajg.2013.72","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300730","article-title":"The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis","volume":"61","author":"Desai TK","year":"2012","unstructured":"Desai TK, Krishnan K, Samala N, Singh J, Cluley J, Perla S, Howden CW. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut. 2012, 61:970-6. 10.1136\/gutjnl-2011-300730","journal-title":"Gut"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-122140","article-title":"Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement","volume":"49","author":"Weusten B","year":"2017","unstructured":"Weusten B, Bisschops R, Coron E, et al.. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017, 49:191-8. 10.1055\/s-0042-122140","journal-title":"Endoscopy"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl H","year":"2005","unstructured":"Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005, 97:142-6. 10.1093\/jnci\/dji024","journal-title":"J Natl Cancer Inst"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1314704","article-title":"Barrett's esophagus","volume":"371","author":"Spechler SJ","year":"2014","unstructured":"Spechler SJ, Souza RF. Barrett's esophagus. N Engl J Med. 2014, 371:836-45. 10.1056\/NEJMra1314704","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren J","year":"2017","unstructured":"Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017, 390:2383-96. 10.1016\/S0140-6736(17)31462-9","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick F","year":"2016","unstructured":"Lordick F, Mariette C, Haustermans K, Obermannov\u00e1 R, Arnold D. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016, 27:50-7. 10.1093\/annonc\/mdw329","journal-title":"Ann Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(03)00191-8","article-title":"Recent clinical investigations examining the association of asthma and gastroesophageal reflux","volume":"115","author":"Harding SM","year":"2003","unstructured":"Harding SM. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am J Med. 2003, 115:39-44. 10.1016\/s0002-9343(03)00191-8","journal-title":"Am J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/17549500701862287","article-title":"Laryngopharyngeal reflux: current concepts in pathophysiology, diagnosis, and treatment","volume":"10","author":"Rees CJ","year":"2008","unstructured":"Rees CJ, Belafsky PC. Laryngopharyngeal reflux: current concepts in pathophysiology, diagnosis, and treatment. Int J Speech Lang Pathol. 2008, 10:245-53. 10.1080\/17549500701862287","journal-title":"Int J Speech Lang Pathol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.08.1458","article-title":"Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report","volume":"150","author":"Kahrilas PJ","year":"2016","unstructured":"Kahrilas PJ, Altman KW, Chang AB, et al.. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest. 2016, 150:1341-60. 10.1016\/j.chest.2016.08.1458","journal-title":"Chest"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.04.176","article-title":"Lifestyle intervention in gastroesophageal reflux disease","volume":"14","author":"Ness-Jensen E","year":"2016","unstructured":"Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016, 14:175-82.e1-3. 10.1016\/j.cgh.2015.04.176","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.06.42","article-title":"The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn","volume":"11","author":"Newberry C","year":"2019","unstructured":"Newberry C, Lynch K. The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn. J Thorac Dis. 2019, 11:1594-601. 10.21037\/jtd.2019.06.42","journal-title":"J Thorac Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach T","year":"2006","unstructured":"Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006, 166:965-71. 10.1001\/archinte.166.9.965","journal-title":"Arch Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand DS","year":"2017","unstructured":"Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017, 11:27-37. 10.5009\/gnl15502","journal-title":"Gut Liver"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1531703","article-title":"Proton pump inhibitors: use and misuse in the clinical setting","volume":"11","author":"Savarino V","year":"2018","unstructured":"Savarino V, Marabotto E, Zentilin P, et al.. Proton pump inhibitors: use and misuse in the clinical setting. Expert Rev Clin Pharmacol. 2018, 11:1123-34. 10.1080\/17512433.2018.1531703","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.5056\/jnm18139","article-title":"Role of acid suppression in acid-related diseases: proton pump inhibitor and potassium-competitive acid blocker","volume":"25","author":"Mori H","year":"2019","unstructured":"Mori H, Suzuki H. Role of acid suppression in acid-related diseases: proton pump inhibitor and potassium-competitive acid blocker. J Neurogastroenterol Motil. 2019, 25:6-14. 10.5056\/jnm18139","journal-title":"J Neurogastroenterol Motil"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21360","article-title":"Gastroesophageal reflux disease: a review","volume":"324","author":"Maret-Ouda J","year":"2020","unstructured":"Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA. 2020, 324:2536-47. 10.1001\/jama.2020.21360","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003243.pub3","article-title":"Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults","volume":"2015","author":"Garg SK","year":"2015","unstructured":"Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2015, 2015:10.1002\/14651858.CD003243.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205544","article-title":"Esophageal sphincter device for gastroesophageal reflux disease","volume":"368","author":"Ganz RA","year":"2013","unstructured":"Ganz RA, Peters JH, Horgan S, et al.. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013, 368:719-27. 10.1056\/NEJMoa1205544","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.4292\/wjgpt.v9.i7.63","article-title":"Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?","volume":"9","author":"Rawla P","year":"2018","unstructured":"Rawla P, Sunkara T, Ofosu A, Gaduputi V. Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?. World J Gastrointest Pharmacol Ther. 2018, 9:63-8.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12359","article-title":"Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects","volume":"26","author":"Kessing BF","year":"2014","unstructured":"Kessing BF, Smout AJ, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neurogastroenterol Motil. 2014, 26:1079-86. 10.1111\/nmo.12359","journal-title":"Neurogastroenterol Motil"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1177\/1553350614526788","article-title":"Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial","volume":"22","author":"Trad KS","year":"2015","unstructured":"Trad KS, Barnes WE, Simoni G, et al.. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov. 2015, 22:26-40. 10.1177\/1553350614526788","journal-title":"Surg Innov"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-017-5431-2","article-title":"Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease","volume":"31","author":"Fass R","year":"2017","unstructured":"Fass R, Cahn F, Scotti DJ, Gregory DA. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease. Surg Endosc. 2017, 31:4865-82. 10.1007\/s00464-017-5431-2","journal-title":"Surg Endosc"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-3731-3","article-title":"Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE\u2122) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial","volume":"29","author":"Zacherl J","year":"2015","unstructured":"Zacherl J, Roy-Shapira A, Bonavina L, et al.. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE\u2122) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015, 29:220-9. 10.1007\/s00464-014-3731-3","journal-title":"Surg Endosc"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.05.028","article-title":"Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux","volume":"14","author":"Ganz RA","year":"2016","unstructured":"Ganz RA, Edmundowicz SA, Taiganides PA, et al.. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol. 2016, 14:671-7. 10.1016\/j.cgh.2015.05.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-015-4539-5","article-title":"Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results","volume":"30","author":"Rodr\u00edguez L","year":"2016","unstructured":"Rodr\u00edguez L, Rodriguez PA, G\u00f3mez B, Netto MG, Crowell MD, Soffer E. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results. Surg Endosc. 2016, 30:2666-72. 10.1007\/s00464-015-4539-5","journal-title":"Surg Endosc"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-012-2476-0","article-title":"Laparoendoscopic single site (LESS) vs. conventional laparoscopic fundoplication for GERD: is there a difference?","volume":"27","author":"Ross S","year":"2013","unstructured":"Ross S, Roddenbery A, Luberice K, et al.. Laparoendoscopic single site (LESS) vs. conventional laparoscopic fundoplication for GERD: is there a difference?. Surg Endosc. 2013, 27:538-47. 10.1007\/s00464-012-2476-0","journal-title":"Surg Endosc"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13233","article-title":"Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis","volume":"31","author":"Ichikawa H","year":"2016","unstructured":"Ichikawa H, Sugimoto M, Sugimoto K, Andoh A, Furuta T. Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis. J Gastroenterol Hepatol. 2016, 31:716-26. 10.1111\/jgh.13233","journal-title":"J Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.382","article-title":"Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T\/IL-1RN*1 (T1) haplotype may protect against the disease","volume":"104","author":"Chourasia D","year":"2009","unstructured":"Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T\/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009, 104:2704-13. 10.1038\/ajg.2009.382","journal-title":"Am J Gastroenterol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307049","article-title":"Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease","volume":"64","author":"Hayat JO","year":"2015","unstructured":"Hayat JO, Gabieta-Somnez S, Yazaki E, et al.. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut. 2015, 64:373-80. 10.1136\/gutjnl-2014-307049","journal-title":"Gut"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13777","article-title":"Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease","volume":"44","author":"Patel A","year":"2016","unstructured":"Patel A, Wang D, Sainani N, Sayuk GS, Gyawali CP. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2016, 44:890-8. 10.1111\/apt.13777","journal-title":"Aliment Pharmacol Ther"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i8-S.7986","article-title":"Non-invasive method for the assessment of gastric acid secretion","volume":"89","author":"Miraglia C","year":"2018","unstructured":"Miraglia C, Moccia F, Russo M, et al.. Non-invasive method for the assessment of gastric acid secretion. Acta Biomed. 2018, 89:53-7. 10.23750\/abm.v89i8-S.7986","journal-title":"Acta Biomed"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.046","article-title":"Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome","volume":"137","author":"Yang L","year":"2009","unstructured":"Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009, 137:588-97. 10.1053\/j.gastro.2009.04.046","journal-title":"Gastroenterology"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-130","article-title":"Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus","volume":"13","author":"Liu N","year":"2013","unstructured":"Liu N, Ando T, Ishiguro K, et al.. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus. BMC Infect Dis. 2013, 13:10.1186\/1471-2334-13-130","journal-title":"BMC Infect Dis"},{"key":"ref64","article-title":"Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics","volume":"13","author":"Ye X","year":"2023","unstructured":"Ye X, Yu F, Zhou J, Zhao C, Wu J, Ni W. Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics. Front Cell Infect Microbiol. 2023, 13:","journal-title":"Front Cell Infect Microbiol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2011.00931.x","article-title":"The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis","volume":"17","author":"Fischbach LA","year":"2012","unstructured":"Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, El-Serag HB. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter. 2012, 17:163-75. 10.1111\/j.1523-5378.2011.00931.x","journal-title":"Helicobacter"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010132","article-title":"Gastroesophageal reflux disease and probiotics: a systematic review","volume":"12","author":"Cheng J","year":"2020","unstructured":"Cheng J, Ouwehand AC. Gastroesophageal reflux disease and probiotics: a systematic review. Nutrients. 2020, 12:10.3390\/nu12010132","journal-title":"Nutrients"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16126","article-title":"Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy","volume":"11","author":"Ghoshal UC","year":"2017","unstructured":"Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver. 2017, 11:196-208. 10.5009\/gnl16126","journal-title":"Gut Liver"},{"key":"ref68","article-title":"Effect of an extra-virgin olive oil enriched with probiotics or antioxidants on functional dyspepsia: a pilot study","volume":"17","author":"Ianiro G","year":"2013","unstructured":"Ianiro G, Pizzoferrato M, Franceschi F, Tarullo A, Luisi T, Gasbarrini G. Effect of an extra-virgin olive oil enriched with probiotics or antioxidants on functional dyspepsia: a pilot study. Eur Rev Med Pharmacol Sci. 2013, 17:2085-90.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy M","year":"2020","unstructured":"El-Salhy M, Hatlebakk JG, Gilja OH, Br\u00e5then Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020, 69:859-67. 10.1136\/gutjnl-2019-319630","journal-title":"Gut"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91782-y","article-title":"Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists","volume":"102","author":"Parsonnet J","year":"1992","unstructured":"Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology. 1992, 102:41-6. 10.1016\/0016-5085(92)91782-y","journal-title":"Gastroenterology"},{"key":"ref71","unstructured":"A study of APG-1252 plus osimertinib (AZD9291) in EGFR TKI resistant NSCLC patients. https.\/\/clinicaltrials.gov\/ct2\/show\/NCT04001777."},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318365","article-title":"Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis","volume":"69","author":"Xiao Y","year":"2020","unstructured":"Xiao Y, Zhang S, Dai N, et al.. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Gut. 2020, 69:224-30. 10.1136\/gutjnl-2019-318365","journal-title":"Gut"},{"key":"ref73","unstructured":"The CALIBER study randomized controlled trial of LINX versus double-dose proton pump inhibitor therapy for reflux disease (CALIBER). https.\/\/clinicaltrials.gov\/ct2\/show\/NCT02505945."},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-018-6403-x","article-title":"Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study","volume":"33","author":"Chimukangara M","year":"2019","unstructured":"Chimukangara M, Jalilvand AD, Melvin WS, Perry KA. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study. Surg Endosc. 2019, 33:1304-9. 10.1007\/s00464-018-6403-x","journal-title":"Surg Endosc"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.022","article-title":"Functional lumen imaging probe for the management of esophageal disorders: expert review from the Clinical Practice Updates Committee of the AGA Institute","volume":"15","author":"Hirano I","year":"2017","unstructured":"Hirano I, Pandolfino JE, Boeckxstaens GE. Functional lumen imaging probe for the management of esophageal disorders: expert review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017, 15:325-34. 10.1016\/j.cgh.2016.10.022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12520","article-title":"Pharmacologic treatments for esophageal disorders","volume":"1325","author":"Blackshaw LA","year":"2014","unstructured":"Blackshaw LA, Bordin DS, Brock C, et al.. Pharmacologic treatments for esophageal disorders. Ann N Y Acad Sci. 2014, 1325:23-39. 10.1111\/nyas.12520","journal-title":"Ann N Y Acad Sci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0115-7","article-title":"Complications of antireflux surgery","volume":"113","author":"Yadlapati R","year":"2018","unstructured":"Yadlapati R, Hungness ES, Pandolfino JE. Complications of antireflux surgery. Am J Gastroenterol. 2018, 113:1137-47. 10.1038\/s41395-018-0115-7","journal-title":"Am J Gastroenterol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291541","article-title":"Wireless pH capsule - yield in clinical practice","volume":"44","author":"Roman S","year":"2012","unstructured":"Roman S, Mion F, Zerbib F, Benamouzig R, Letard JC, Bruley des Varannes S. Wireless pH capsule - yield in clinical practice. Endoscopy. 2012, 44:270-6. 10.1055\/s-0031-1291541","journal-title":"Endoscopy"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03933.x","article-title":"Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies","volume":"29","author":"Sharma P","year":"2009","unstructured":"Sharma P, Shaheen NJ, Perez MC, Pilmer BL, Lee M, Atkinson SN, Peura D. Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies. Aliment Pharmacol Ther. 2009, 29:731-41. 10.1111\/j.1365-2036.2009.03933.x","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281317-gastroesophageal-reflux-disease-new-insights-and-treatment-approaches","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T09:49:28Z","timestamp":1724492968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281317-gastroesophageal-reflux-disease-new-insights-and-treatment-approaches"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":79,"URL":"https:\/\/doi.org\/10.7759\/cureus.67654","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,24]]}}}